Amazon will discontinue its Amazon One palm-scanning payment and entry technology at retail locations in 2026, marking a retreat from one of its most ambitious physical commerce experiments.
After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.
Amid a flurry of bank mergers and acquisitions reshaping Texas, San Antonio-based Frost Bank is doubling down on its organic growth strategy. CEO Phil Green asserts the bank has "zero interest" in M&A, positioning itself to win customers dislocated by industry upheaval.
New federal data reveals a significant year-over-year jump in energy costs for November, with natural gas prices soaring and electricity rates climbing, squeezing household budgets amid fluctuating demand and generation patterns.
Alphabet's planned $13 billion investment in Waymo, valuing the self-driving unit at $110 billion, challenges the long-held view of its moonshot projects as mere financial drains and positions autonomous driving as a core future asset.
Despite a post-earnings slump and near 52-week lows, Abbott Laboratories' resilient medical device unit, strategic expansion in diabetes care, and a landmark acquisition in cancer diagnostics paint a promising long-term picture for this Dividend Aristocrat.
The iconic outdoor apparel brand Eddie Bauer is preparing to file for Chapter 11 bankruptcy and close its physical stores across the U.S. and Canada, marking a decisive shift to a digital-first future while retaining some international retail presence.
As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.
The long-term agreement, extending to the late 2030s, centers on the joint evolution of ZF's flagship 8-speed automatic transmission for next-generation electrified vehicles, signaling deep collaboration in the auto industry's transition.
Despite OPEC+ maintaining production cuts, crude benchmarks fell sharply on Monday, pulling energy stocks like ConocoPhillips down with them as immediate fears of a supply disruption in the Persian Gulf subsided.
Ford Motor Company is reportedly in preliminary discussions with Chinese tech and auto newcomer Xiaomi, exploring a joint venture that could facilitate Xiaomi's entry into U.S. vehicle manufacturing, according to sources familiar with the matter.
The Walt Disney Company's latest quarterly results surpassed Wall Street's modest expectations, yet its stock failed to rally. While its Experiences division continues to be a profit powerhouse and streaming turns a corner, broader challenges and a shrinking 'beat' margin leave investors watching for a catalyst.
Beijing has lowered punitive tariffs on key EU dairy products, offering some relief to exporters like Arla and Lactalis. While welcomed as a de-escalation, European trade bodies argue the remaining duties are unjustified and call for continued negotiations to resolve the trade dispute.
From Denny's to Outback Steakhouse, a wave of closures is sweeping through America's familiar dining landscape. Experts point to a perfect storm of inflation, shifting consumer habits, and financial pressures reshaping where we eat.
While AI's role in headline-grabbing discoveries like AlphaFold is celebrated, Anthropic is forging a new path. Through partnerships with the Allen Institute and HHMI, the company is embedding Claude AI into the unglamorous, time-consuming groundwork of research—betting that efficiency gains in data analysis and coordination will compress decades of scientific progress.
Despite a challenging year marked by a steep sell-off after disappointing Medicare rate updates, analysts are showing tentative signs of increased confidence in the managed care giant, though a consensus 'Hold' rating prevails.
Pharmaceutical giant Eli Lilly is investing $3.5 billion to build a new manufacturing facility in rural Pennsylvania, marking its latest move in a massive U.S. expansion aimed at meeting soaring demand for next-generation obesity treatments and capitalizing on reshoring incentives.
The SEC appoints a new slate of leaders to the Public Company Accounting Oversight Board, signaling a potential shift in regulatory focus and internal dynamics as a prominent advocate for technology innovation departs.
AIGH Capital Management has liquidated its entire position in semiconductor firm MaxLinear, a move that coincides with the chipmaker's recent strong quarterly earnings report, raising questions about the fund's strategy.
The Walt Disney Company posted a mixed fiscal first quarter, with its Experiences division reaching an unprecedented $10 billion in revenue. While streaming profits soared, a warning of softening U.S. park demand and a looming CEO transition cast a shadow over the results.
